Inclusion Body Myositis
📧 Sign up to get email alerts when something new happens for Inclusion Body Myositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Environmental Risk Factors for Myositis in Military Personnel
A completed NIEHS-sponsored clinical study evaluated environmental risk factors for myositis in military personnel, including dermatomyositi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adult and Juvenile Myositis
This entry reports that a NIEHS-sponsored clinical trial investigating adult and juvenile myositis is currently recruiting for dermatomyosit…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: IBM Dietary Surveillance Study
This clinical trial update announces a study titled IBM Dietary Surveillance Study conducted by Manchester Metropolitan University. The tria…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease [NA]
A clinical trial is evaluating the effects of whole-body electrical muscle stimulation on adults with various neuromuscular diseases and is …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Sporadic Inclusion Body Myositis Natural History Study
A natural history study of sporadic inclusion body myositis and inclusion body myositis at the University of California, Irvine is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Phase III Trial of Sirolimus in IBM [Phase 3]
Phase III trial of sirolimus in inclusion body myositis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Ruxolitinib Treatment in Inclusion Body Myositis [Phase 2]
Phase 2 study evaluating ruxolitinib for inclusion body myositis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Development and validation of the FBIndex, a tool to assess falls risk in patients with various neuromuscular disorders.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis [Phase 2, Phase 3]
This entry notes a long-term extension study of Ulviprubart (ABC008) in Inclusion Body Myositis, spanning Phase 2 and Phase 3, which is curr…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. [NA]
This clinical trial update outlines a study evaluating whether assistive gait devices, following a training period, can reduce fall risk in …
-
CLINICAL_TRIALS research · 2017-02-09Clinical Trial Update: Natalizumab in Inclusion Body Myositis (IBM) [Phase 1]
A Phase 1 clinical trial evaluating natalizumab for inclusion body myositis is ongoing, with the current status listed as unknown.
-
CLINICAL_TRIALS research · 2015-09-01Clinical Trial Update: Natural History in CCFDN and IBM Syndromes
This completed observational study from Ludwig-Maximilians-University Munich examines the natural history of Congenital cataracts, facial dy…